Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)

This study has been withdrawn prior to enrollment.
(funding was withdrawn from Drug company)
Sponsor:
Collaborator:
Celgene Corporation
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00903942
First received: May 15, 2009
Last updated: May 18, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)